ArticleJournal for immunotherapy of cancer2022

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.

Rocio Garcia-Carbonero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.